Liposomal imatinib-mitoxantrone combination: formulation development and therapeutic evaluation in an animal model of prostate cancer. [electronic resource]
Producer: 20101228Description: 81-90 p. digitalISSN:- 1097-0045
- Adenocarcinoma -- drug therapy
- Animals
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Benzamides
- Cell Line, Tumor
- Disease Models, Animal
- Humans
- Imatinib Mesylate
- Liposomes
- Male
- Mice
- Mice, Nude
- Mitoxantrone -- administration & dosage
- Piperazines -- administration & dosage
- Prostatic Neoplasms -- drug therapy
- Pyrimidines -- administration & dosage
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.